[1] Lauterio A, De Carlis R, Centonze L, et al. Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma. Cancers (Basel), 2021, 13(15): 3657. [2] 陆才德, 吴胜东, 房炯泽, 等. 门静脉切除重建在肝门部胆管癌手术切除中的应用分析. 中华肝胆外科杂志, 2022, 28(5): 356-361. [3] Zhou Q, Dong G, Zhu Q, et al. Modification and comparison of CT criteria in the preoperative assessment of hepatic arterial invasion by hilar cholangiocarcinoma. Abdom Radiol (NY), 2021, 46(5): 1922-1930. [4] Zhang JZ, Yang CX, Gao S, et al. Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification. World J Surg Oncol, 2023, 21(1):239. [5] Toki M, Tateishi H, Yoshida T, et al. Utilization of a new technology of 3D biliary CT for ERCP-related procedures: a case report. BMC Gastroenterol, 2020, 20(1): 158. [6] 中华医学会外科学分会胆道外科学组, 解放军全军肝胆外科专业委员会. 肝门部胆管癌诊断和治疗指南(2013版). 中华外科杂志, 2013, 51(10): 865-871. [7] Zeng N, Tao H, Fang C, et al. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma. World J Surg Oncol, 2016, 14(1):44. [8] Wang Y, Liu PP, Yang LL. Stent insertion for hilar cholangiocarcinoma: a meta-analysis of comparison between unilateral and bilateral stenting. Prz Gastroenterol, 2021, 16(4): 383-389. [9] 曾宁, 杨剑, 项楠, 等. 三维可视化联合3D打印在Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌个体化精准外科治疗中的应用. 南方医科大学学报, 2020, 40(8): 1172-1177. [10] Jianxiong W, Yu W, Juyi W, et al. Intravenous combined with intrabiliary contrast-enhanced ultrasound in the evaluation of resectability of hilar cholangiocarcinomas. J Clin Ultrasound, 2022, 50(7):931-939. [11] 谢慧, 王亮亮, 江凯, 等 .多层螺旋CT与高场强磁共振LAVA增强对乙型肝炎肝硬化背景小肝癌的诊断价值对比. 肝脏, 2022, 27(08):895-897+907. [12] Hong SB, Lee NK, Kim S, et al. Structured reporting of CT or MRI for perihilar cholangiocarcinoma: usefulness for clinical planning and interdisciplinary communication. Jpn J Radiol, 2021, 39(4): 349-356. [13] 杨骥, 黄强, 王成, 等. 计算机三维重建技术在指导肝门部胆管癌手术中的应用. 中华肝胆外科杂志, 2021, 27(2): 114-117. [14] Fang CH, Zhang P, Zhou WP, et al. Efficacy of three-dimensional visualization technology in the precision diagnosis and treatment for primary liver cancer: a retrospective multicenter study of 1 665 cases in China. Zhonghua Wai Ke Za Zhi, 2020, 58(5): 375-382. [15] Fang C, An J, Bruno A, et al. Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases. Hepatol Int, 2020, 14(4): 437-453. [16] Lopez-Lopez V, Gomez-Perez B, de Vicente E, et al. Next-generation three-dimensional modelling software for personalized surgery decision-making in perihilar cholangiocarcinoma: multicentre study. Br J Surg, 2021, 108(12): 394-395. |